Khan Zakir, Shen Xiao Z, Bernstein Ellen A, Giani Jorge F, Eriguchi Masahiro, Zhao Tuantuan V, Gonzalez-Villalobos Romer A, Fuchs Sebastien, Liu George Y, Bernstein Kenneth E
Department of Biomedical Sciences and.
Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA.
Blood. 2017 Jul 20;130(3):328-339. doi: 10.1182/blood-2016-11-752006. Epub 2017 May 17.
Angiotensin-converting enzyme (ACE) inhibitors are widely used to reduce blood pressure. Here, we examined if an ACE is important for the antibacterial effectiveness of neutrophils. ACE knockout mice or mice treated with an ACE inhibitor were more susceptible to bacterial infection by methicillin-resistant (MRSA). In contrast, mice overexpressing ACE in neutrophils (Neu mice) have increased resistance to MRSA and better in vitro killing of MRSA, , and ACE overexpression increased neutrophil production of reactive oxygen species (ROS) following MRSA challenge, an effect independent of the angiotensin II AT1 receptor. Specifically, as compared with wild-type (WT) mice, there was a marked increase of superoxide generation (>twofold, < .0005) in Neu neutrophils following infection, whereas ACE knockout neutrophils decreased superoxide production. Analysis of membrane p47-phox and p67-phox indicates that ACE increases reduced NAD phosphate oxidase activity but does not increase expression of these subunits. Increased ROS generation mediates the enhanced bacterial resistance of Neu mice because the enhanced resistance is lost with DPI (an inhibitor of ROS production by flavoenzymes) inhibition. Neu granulocytes also have increased neutrophil extracellular trap formation and interleukin-1β release in response to MRSA. In a mouse model of chemotherapy-induced neutrophil depletion, transfusion of ACE-overexpressing neutrophils was superior to WT neutrophils in treating MRSA infection. These data indicate a previously unknown function of ACE in neutrophil antibacterial defenses and suggest caution in the treatment of certain individuals with ACE inhibitors. ACE overexpression in neutrophils may be useful in boosting the immune response to antibiotic-resistant bacterial infection.
血管紧张素转换酶(ACE)抑制剂被广泛用于降低血压。在此,我们研究了ACE对中性粒细胞抗菌效力是否重要。ACE基因敲除小鼠或用ACE抑制剂处理的小鼠对耐甲氧西林金黄色葡萄球菌(MRSA)感染更易感。相反,在中性粒细胞中过表达ACE的小鼠(Neu小鼠)对MRSA的抵抗力增强,且在体外对MRSA的杀伤能力更强,并且ACE过表达增加了MRSA攻击后中性粒细胞活性氧(ROS)的产生,这一效应独立于血管紧张素II AT1受体。具体而言,与野生型(WT)小鼠相比,感染后Neu中性粒细胞中超氧化物生成显著增加(>两倍,P<0.0005),而ACE基因敲除的中性粒细胞中超氧化物产生减少。对膜p47 - phox和p67 - phox的分析表明,ACE增加了还原型烟酰胺腺嘌呤二核苷酸磷酸氧化酶活性,但并未增加这些亚基的表达。ROS生成增加介导了Neu小鼠增强的细菌抵抗力,因为DPI(一种黄素酶产生ROS的抑制剂)抑制后增强的抵抗力消失。Neu粒细胞对MRSA的反应中中性粒细胞胞外陷阱形成和白细胞介素 - 1β释放也增加。在化疗诱导的中性粒细胞减少的小鼠模型中,输注过表达ACE的中性粒细胞在治疗MRSA感染方面优于WT中性粒细胞。这些数据表明ACE在中性粒细胞抗菌防御中具有先前未知的功能,并提示在使用ACE抑制剂治疗某些个体时应谨慎。中性粒细胞中ACE过表达可能有助于增强对抗生素耐药细菌感染的免疫反应。